mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.099 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |